Youming Zhang
Director/Board Member at FUFENG GROUP LIMITED
Youming Zhang active positions
| Companies | Position | Start | End |
|---|---|---|---|
| FUFENG GROUP LIMITED | Director/Board Member | 2021-03-31 | - |
| Independent Dir/Board Member | 2021-03-31 | - | |
| Shandong University | Corporate Officer/Principal | - | - |
Career history of Youming Zhang
Former positions of Youming Zhang
| Companies | Position | Start | End |
|---|---|---|---|
Gene Bridges GmbH
 Gene Bridges GmbH BiotechnologyHealth Technology Gene Bridges GmbH specializes in DNA engineering. The firm focuses on market development, product development and innovation of DNA engineering in functional genomics studies and providing customer-specific solutions for DNA engineering projects. Its patented Red/ET Recombination, also known as lambda-red mediated recombination or recombineering, enables cloning and modification of DNA molecules regardless of restriction sites and is useful for the generation of targeting vectors necessary to create transgenic mouse models. The company was founded in 2000 and is headquartered in Heidelberg, Germany. | Chief Tech/Sci/R&D Officer | - | 2012-12-31 |
| The European Molecular Biology Laboratory | Corporate Officer/Principal | - | - |
Training of Youming Zhang
| Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
| Xiamen University | Undergraduate Degree |
| Peking Union Medical College | Graduate Degree |
Statistics
International
| China | 5 |
| Germany | 4 |
Operational
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectoral
| Consumer Services | 6 |
| Consumer Non-Durables | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| FUFENG GROUP LIMITED | Consumer Non-Durables |
| Private companies | 1 |
|---|---|
Gene Bridges GmbH
Gene Bridges GmbH BiotechnologyHealth Technology Gene Bridges GmbH specializes in DNA engineering. The firm focuses on market development, product development and innovation of DNA engineering in functional genomics studies and providing customer-specific solutions for DNA engineering projects. Its patented Red/ET Recombination, also known as lambda-red mediated recombination or recombineering, enables cloning and modification of DNA molecules regardless of restriction sites and is useful for the generation of targeting vectors necessary to create transgenic mouse models. The company was founded in 2000 and is headquartered in Heidelberg, Germany. | Health Technology |
- Stock Market
- Insiders
- Youming Zhang
- Experience